[1]
Bolaños-Díaz, R. et al. 2016. Evaluation of the cost-effectiveness of two alternative human papillomavirus vaccines as prophylaxis against uterine cervical cancer. Revista Peruana de Medicina Experimental y Salud Pública. 33, 3 (Aug. 2016), 411–8. DOI:https://doi.org/10.17843/rpmesp.2016.333.2294.